Randomised, double-blind, multicentre, mixed-methods, dose-escalation feasibility trial of mirtazapine for better treatment of severe breathlessness in advanced lung disease (BETTER-B feasibility)

Irene J. Higginson, Andrew Wilcock, Miriam J. Johnson, Sabrina Bajwah, Natasha Lovell, Deokhee Yi, Simon P. Hart, Vincent Crosby, Heather Poad, David Currow, Emma Best, Sarah Brown, BETTER-B Feasibility Trial Group, I Higginson, Jackie Pullen, Katie Neville, Victoria Hiley, Vicky Liversedge, Sarah Brown, Avie-Lee TillotsonNatasha Lovell, Miriam J. Johnson, Andrew Wilcock, David Currow, Deokhee Yi, M Paine

    Research output: Contribution to journalArticlepeer-review

    1 Citation (Scopus)
    6 Downloads (Pure)

    Fingerprint

    Dive into the research topics of 'Randomised, double-blind, multicentre, mixed-methods, dose-escalation feasibility trial of mirtazapine for better treatment of severe breathlessness in advanced lung disease (BETTER-B feasibility)'. Together they form a unique fingerprint.

    Medicine & Life Sciences